UNSPSC 51413001: Aminoethyl nitrate

This classification denotes a vasodilating agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S1IA7R2J48. European Medicines Agency schedules Aminoethyl nitrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05439MIG. Aminoethyl nitrate generally arises in the molecular formula C2H6N2O3. The term AMINOETHYL NITRATE is an International Non-Proprietary Name or INN. Most nations schedule aminoethyl nitrate under HS 29225000 and SITC 51467.

As of Q4 2014, AMINOETHYL NITRATE remains the US FDA Preferred Term for this commodity. Aminoethyl nitrate bears US NLM identifiers UMLS ID C2698088 and NCI Concept Code C74414. SMILES: O([N](=O)O)CCN.

UNSPSC 51413001 Aminoethyl nitrate is a Commodity code that in practice covers emergency medical medications and pharmaceutical supplies procured by state and local health and public safety agencies. The recent solicitation activity under this code reflects procurement of advanced life support medications — including vasopressors, cardiac agents, and other drugs administered by paramedics and firefighters in emergency response settings. State and local issuing bodies acquiring under this code include municipal fire departments and their parent cities' purchasing offices, which source these medications for active inventory management and supply chain continuity. Vendors must meet strict pharmaceutical handling, storage, and expiration-date requirements, warrant product integrity for a defined period, and comply with OSHA hazard communication and federal accessibility standards for all documentation and product data sheets.

The City of Tampa Purchasing Department posted an IFB (Bid No. 26P00188) on April 24, 2026, for Advanced Life Support Medications to be used by Tampa Fire Rescue in Hillsborough County, Florida, with a response deadline of April 8, 2026, and an estimated contract value of $40,000.00. The solicitation required supply of four specific medications — Labetalol HCI 100mg vials (370 units), Epinephrine 1:10,000 injections (1,810 units), Adenosine 6mg vials (330 units), and Diltiazem 25mg vials (1,020 units) — with a one-year initial contract term and options to renew for two additional one-year periods. The bid included a 5 percent discount sheltered market designation for Small Local Business Enterprises (SLBEs), not to exceed $10,000, with firm pricing required to include all shipping, freight, and applicable taxes, and delivery mandated within ten calendar days of order receipt.